PineTree Therapeutics

Cambridge, MA · Founded 2019 · Privately Held (backing)

Developer of biological therapeutics technology designed to treat unmet needs in oncology and infectious diseases. PineTree Therapeutics is based in Cambridge, MA and was founded in 2019. Its last reported valuation was $358 million in Aug 2025. It has raised $97.5 million.

Last reported valuation
$358.0M
Oct 2026
Priced at
—
Total raised
$97.5M
Last round
—

Who backs PineTree Therapeutics?

19 investors
InvestorType
Korea Investment PartnersVenture capital
Smilegate InvestmentVenture capital
InterVestVenture capital
STIC VenturesVenture capital
Schmidt (South Korea)Venture capital
Partners InvestmentVenture capital
SJ Investment PartnersVenture capital
LogInvestment—
TKG VenturesVenture capital
AstraZeneca—
+ 9 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

PineTree Therapeutics investors

19 investors are on record for PineTree Therapeutics, including Korea Investment Partners, Smilegate Investment, InterVest and STIC Ventures. By type, the record holds 8 venture capital firms.

Free account
More of PineTree Therapeutics with a free account
  • ·The complete investor list: 19 names
  • ·Watch PineTree Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 19 firms already write checks for companies like PineTree Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View

PineTree Therapeutics Investors — Who Backs PineTree Therapeutics? | Premier Alternatives